ERBB2 and neoplasm: Trastuzumab recognizes a HER2 epitope located on extracellular region IV of this protein and can suppress tumor cell growth through several mechanisms including the overall downregulation of HER2 expression, the disruption of the cleavage of this HER2 extracellular region.